Clesrovimab
Based on 5 publication(s) in Google Scholar
Clesrovimab (MK-1654) is a humanized IgG1 monoclonal antibody targeting the respiratory syncytial virus (RSV) protein F. Clesrovimab binds to pre-fusion and post-fusion forms of RSV-A fusion protein with high affinity, with corresponding KD values of 71 pM and 480 pM, respectively. Clesrovimab is applicable for the research of RSV infection.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.77%
- CAS 番号: 2429913-18-6
- 分子量:146.75 kDa
-
保管条件:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
MedChemExpress(MCE)の使用を引用している文献 Clesrovimab
More
生物活性
製品説明
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
RSV-F
体外実験
Clesrovimab potently neutralizes historical and contemporary RSV A and B isolates in Hep-2 cells, with median EC50 values of 25 pM, 30 pM, 121 pM, and 130 pM for historical RSV A, historical RSV B, contemporary RSV A, and contemporary RSV B isolates, respectively[1].
Clesrovimab selects for resistant variants during in vitro serial passage of RSV A and RSV B, with >3800-fold reduced susceptibility in RSV A variants and >360-fold reduced susceptibility in an RSV B variant[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
アクセッション番号
A0A0X8XRK2
Conjugated
Unconjugated
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 kappa
アプリケーション
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Fusion glycoprotein F0/F Protein, HRSV (sf9, His, HY-P75182) can bind Clesrovimab. The EC50 for this effect is 4.686 ng/mL.
化学情報
-
CAS 番号 2429913-18-6
-
性状 Liquid
-
分子量 146.75 kDa
-
Color Colorless to light yellow
-
SMILES
[Clesrovimab]
-
別名
MK-1654
-
輸送条件
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (5)
-
Journal Impact Factor
-
Most Recent
-
J Infect Dis
Respiratory Syncytial Virus Fusion Protein Epitope-specific Antibodies and Neutralizing Activities against Various Respiratory Syncytial Virus Strains. [Abstract]2025 Jul 18:jiaf375. PMID: 40675573 -
J Infect Dis
Amino acid substitutions in the fusion protein of respiratory syncytial virus in Fukushima, Japan during 2008-2023 and their effects. [Abstract]2025 Jul 11;231(6):1544-1552. PMID: 39719011 -
-
-
純度とドキュメンテーション
-
データシート (277 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)